CN Patent

CN103874696B — 作为激酶抑制剂的喹唑啉衍生物及其使用方法

Assigned to Suzhou Taolue Biotechnology Co Ltd · Expires 2015-06-03 · 11y expired

What this patent protects

本发明公开了一种式(I)所示喹唑啉、及其药学上可接受的盐、溶剂化物和水合物。本发明的化合物具有蛋白激酶抑制活性，并且将有益于蛋白激酶介导的疾病或病症的治疗。

USPTO Abstract

本发明公开了一种式(I)所示喹唑啉、及其药学上可接受的盐、溶剂化物和水合物。本发明的化合物具有蛋白激酶抑制活性，并且将有益于蛋白激酶介导的疾病或病症的治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN103874696B
Jurisdiction
CN
Classification
—
Expires
2015-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Taolue Biotechnology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.